# PR-104 in Treating Patients With Advanced Solid Tumors

> **NCT00349167** · PHASE1 · COMPLETED · sponsor: **Proacta, Incorporated** · enrollment: 27 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** PR-104
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00349167
- **Lead sponsor:** Proacta, Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2012-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00349167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00349167, "PR-104 in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00349167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*